For Tim Ferriss, the best-selling author, podcaster, and investor, the decision to devote his philanthropy to research into psychedelic drugs is built on a solid foundation of peer-reviewed science. “I’ve spent hundreds of hours interacting with researchers to get a better understanding of the science,” he says.
It’s also deeply personal. Ferriss’s best friend from childhood died of a fentanyl overdose. An aunt, after injuring her shoulder, became addicted to Percocet and alcohol and died last year. Recently, Ferriss decided to help fund research at John Hopkins to see if psilocybin-assisted therapy could treat opioid addiction.
We’re sorry. Something went wrong.
We are unable to fully display the content of this page.
The most likely cause of this is a content blocker on your computer or network. Please make sure your computer, VPN, or network allows javascript and allows content to be delivered from v144.philanthropy.com and chronicle.blueconic.net.
Once javascript and access to those URLs are allowed, please refresh this page. You may then be asked to log in, create an account if you don't already have one, or subscribe.
If you continue to experience issues, contact us at 202-466-1032 or help@chronicle.com